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Background/aim: Although migraine is a common disorder, there is a lack of research investigating the possible relationship between
migraine and oral health. The aim of the present study was to explore the relationship between temporomandibular disorders, bruxism,
dental caries, periodontal status, and migraine disorder in a multicenter, parallel, case-controlled clinical study.
Materials and methods: A total of 2001 participants were divided into two groups: migraineurs (nm = 998) and nonmigraineurs (nh =
1003). International Headache Society’s Second Edition of International Classification of Headache Disorders and modified Migraine
Disability Assessment surveys were administered to evaluate the level of migraine; a pretreatment questionnaire and the World Health
Organization oral health assessment form were used to determine the oral comorbidities and their possible effects on DMFT index,
gingival plaque index, existence of temporomandibular disorders, bruxism, and consistency of daily oral hygiene habits.
Results: The mean age was 39.6 ± 10.5 years. Female patients seemed to experience migraine attacks more than male patients (64%). The
frequency of gastroesophageal reflux was higher in migraineurs in comparison with nonmigraineurs (47%) and tooth wear and abrasion
also seemed more frequent (76%). DMFT and plaque index scores showed significant differences for both groups.
Conclusion: There is a strong relationship between migraine and oral health status. The existence of reflux in addition to migraine leads
to higher dental problems.
Key words: Migraine, oral health, gastroesophageal reflux disease, dental caries, gingival plaque index

1. Introduction
Migraine headache is one of the primary disabling clinical
neurological problems afflicting millions of individuals
(1,2). This disorder is most commonly experienced between
the ages of 15 and 55 years, and 70% to 80% of sufferers
have a family history of migraine (3). A widely accepted
neurovascular theory of migraine etiology consists of
dural and meningeal vascular dilatation, perivascular
inflammation, and nociceptor activation (4). The reflection
of migraine pain to the temporomandibular, facial, and
maxillary areas has been ascribed to vascular dilatation
and inflammation of the trigeminal nerve, which emanates
from the brainstem and innervates the orofacial area (5).
Although a relationship between the vascular etiology of
migraine and orofacial syndrome theoretically exists, the
exact nature of the pain remains elusive, as do those of the
accompanying symptoms and comorbidities, including
nausea, vomiting, gastroesophageal reflux disease
* Correspondence: dtcempeskersoy@hotmail.com
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(GERD), irritation, and fatigue (6,7). These symptoms and
comorbidities could possibly affect oral health and care;
therefore, a dental professional’s evaluation and treatment
might be essential for migraineurs (8).
One of the most encountered oral comorbidities is
GERD, which is caused by the backflow of acidic gastric
juice (pH: 1.0–3.0) into the oral cavity due to the condition
itself or to vomiting during acute migraine attacks (9,10).
Although the damaging effects of gastric juice depend
on the duration of exposure and frequency, it can cause
extensive erosions on tooth surfaces, particularly on the
lingual side (11). It is a fact that the erosion level of the
teeth is much higher in chronic migraine patients and
eroded tooth surfaces are more likely to be susceptible to
dental caries and periodontal problems (12).
The systemic conditions of migraine patients are also
correlated with dental status. The positive correlation
between migraine and the presence of gastrointestinal
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disorders (GIDs) has previously been established in many
clinical and epidemiological studies (13). The clinical
features of GIDs in migraine patients are most commonly
characterized by the effects of acidic gastric juice on
mandibular teeth (14). Several studies have demonstrated
possible relationship between cardiovascular diseases
(CVDs) and migraine (4,15,16). The functional significance
of CVDs in migraine patients is that poor oral hygiene
could be a predisposing factor for infective endocarditis
caused by streptococcal bacteria (17).
Temporomandibular disorder (TMD) is a collective
term that encompasses a number of clinical problems that
involve the masticatory muscles, the temporomandibular
joint (TMJ), and associated structures (18). The most
common symptom of TMD is pain, usually located from
the temporomandibular region to the retromandibular
area through the masticatory muscles, and usually
confused with chronic headaches reflected to these areas
(19). Although not as well characterized as the prevalence
of common headache syndromes, the prevalence of TMD
in migraineurs has ranged from 22% to 52% (20).
According to epidemiological studies of adult
populations, 50% to 75% of migraineurs have at least
one sign of comorbidity, and nearly 35% have at least one
symptom of TMD (18). The aim of the present study was
to determine the relationships among oral hygiene, dental
status, accompanying systemic conditions, and chronic
migraine status in a case-control clinical study, to prove the
hypothesis that there is a relationship between migraine
and oral health and care.
2. Materials and methods
2.1. Study design
Two thousand six hundred and eighty one patients
(between 18 and 60 years old and of both sexes) who
presented at the neurology clinics of Izmir Ataturk Training
and Education Hospital and Ege University and Behcet Uz
Training Hospital were invited to participate in this study.
A case-control, observational, and multicenter study was
designed; the study was approved by the Ethics Committee
of Ege University (reg no: 11-10.1/9) and written consent
was obtained from all participants. Patients were examined
by two neurologists who have experience in the headache
field and clinical diagnosis of the neurologist was used as
the gold standard. The final diagnosis was made according
to the International Headache Society’s Second Edition
of International Classification of Headache Disorders to
evaluate the existence, level, and effects of migraine on
daily life (21,22). Prior to the study, Migraine Disability
Assessment tests, modified for the present study (MS-Q
and MIDAS), were also administered to each participant
who was under medication for migraine to determine

the systemic, socioeconomic, educational, and habitual
statuses and the frequency of comorbid factors affecting
the patient’s quality of life (Figure) (2,21,23). Some of the
comorbid factors such as photophobia, motion sickness,
and dizziness were also transferred directly from hospital
records to the patients’ charts. Both migraine patients and
nonmigraineurs were informed about the study design,
and the patients who accepted the terms were included
in the volunteer pool. The postevaluation stage involved
the creation of two groups: Group 1 consisted of patients
diagnosed with migraine (nm = 998) and Group 2 consisted
of nonmigraineurs as a control group (nh = 1003),
according to the block and unregistered randomization
type. Therefore, all of the participants in both groups were
chosen from similar socioeconomic levels; also, they were
university graduates, nonsmokers, and nondrinkers and
had average body mass indices (BMI: 25–29). Participants
who were unable to complete the questionnaires, smokers,
alcohol users, and patients who did not approve of the
terms were excluded (n = 40). Patients who were unable
to complete oral examinations (9), questionnaires (3.4%),
and patients with additional psychological problems
(7.1%) that could affect the study results were classified as
missing data and also excluded (n = 189).
Each new patient with/without migraine was offered
an evaluation by two different restorative dentistry
specialists from Ege University at the same health center
facility on the same day. To establish a double-blind study,
both of the examiners were unaware of which group was
being examined, and the interexaminer reliability was
assessed with correlation coefficients (ICCs), using mixed
effects regression models. The evaluation consisted of the
application of a questionnaire (pretreatment form) and an
oral examination to evaluate the dental and periodontal
status (Figure). The questionnaire had three categories to
evaluate oral hygiene habits, previous dental experiences,
and common problems/requests in correlation with
migraine and subtypes. The oral examinations were
performed using the World Health Organization oral
health assessment form (Geneva, 2009) to record previous
dental treatments, periodontal status, bruxism, dental
caries (ICDAS criteria), and TMD. Erosion and abrasions
were categorized according to the Bartlett and Shah
classification (1).
2.2. Statistical analysis
All of the data acquired from the questionnaires and oral
assessment forms, such as the patients’ sociodemographic
and clinical properties, age, sex, and family history of
migraine were descriptively analyzed; means, standard
deviations, and 95% confidence intervals were calculated
for quantitative variables and frequencies for qualitative
variables. Adjustment was made for individual’s sex,
age, systemic conditions, existence of comorbidities, and
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Figure. Modified MS-Q and MIDAS surveys to determine the level of migraine, systemic, socioeconomic, educational, and habitual
statuses of the patients and the frequency of accompanying comorbidities.

overall dental health and care status. All analyses were
weighted to account for the individual survey sample
designs. Analyses considered that observations within each
cluster of survey were not independent from each other.
The estimation of the sample size was performed with a
power analysis test using SPSS software, version 17.0. The
evaluation of migraine distribution by age and sex was
performed by the chi-square test with a significance level
of 0.05. The independent t-test was used to compare the
systemic conditions between the patients with migraine
and nonmigraineurs. Pearson’s correlation test was used to
assess the association between oral healthcare and DMFT/
GPI scores and potential confounders.
3. Results
The data collected from 2001 participants were
analyzed and revealed nonnegligible differences. Of the
participants, 36% were male (n = 720) and 64% were
female (n = 1281). The sex distribution in both groups
was similar to standardize the research (M/F: 34/66 vs.
38/62). The mean age of the participants was 39.57 ±
10.49 years old, ranging from 21 to 60 years old. Female
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participants suffered from migraine significantly more
than male participants (P < 0.05). Systemic diseases and
disorders such as cardiovascular and gastrointestinal
system diseases, metabolic disorders, and systemic lupus
erythematosus, showed no significant differences among
the participants (Table 1) (P > 0.05). While photophobia
was the most common accompanying symptom,
phonophobia, nausea, and gastroesophageal reflux were
also found to be high. The other accompanying factors
shown in Table 2 in migraineurs were statistically
different from nonmigraineurs (P < 0.05).
The frequency of GERD was 42% in the migraine
patients and 18% in the control group (P < 0.05).
Gastrointestinal problems such as gastritis and ulcers were
much more common in nonmigraineurs (12%, P < 0.05)
(Table 1). The rate of migraine patients who suffered from
bruxism and TMD were relatively high in comparison
with the control group (49%, P < 0.05), while correlation
analysis showed that the frequency of erosion and
abrasions was positively correlated with the existence of
bruxism (P < 0.05). Details, including systemic conditions,
are also shown in Table 1.
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Table 1. Evaluation of patients with migraine and nonmigraineurs for systemic diseases.
Male

Female

Male

Female

Group 1 vs.
Group 2 #

Hypertension (HTN)

70

161

62

148

0.866

Cardiac dysrhythmia

21

59

30

32

0.582

Chronic obstructive pulmonary disease (COPD)

19

12

17

15

0.299

Asthma

9

13

10

15

0.604

Gastroesophageal reflux (GERD)

175

248

82

101

0.000*

Gastritis-gastric ulcer

31

29

22

36

0.348

Diabetes mellitus (DM)

30

107

32

74

0.509

Thyroid disorders

9

61

11

50

0.758

28

58

31

49

0.287

9

24

10

18

0.410

Systemic conditions
Cardiovascular diseases

Respiratory diseases

Gastrointestinal system diseases

Endocrine-metabolic diseases

Autoimmune diseases
Systemic lupus (SLE)
Nephrological diseases
Glomerulonephritis

*: significant difference.
#: Group 1: Migraine patients; Group 2: Nonmigraineurs.
Table 2. The subtypes of migraine in relation to accompanying symptoms.
Accompanying symptoms of migraine in correlation with subtypes
Status

Abdominal

Retinal

Specific migraine

Basilar-type

Hemiplegic

Migraine

n

migrainosus

migraine

migraine

with aura

migraine

migraine

without aura

(%)

Phonophobia

4 (100%)

2 (40%)

6 (33%)

271 (86%)

1 (25%)

1 (33%)

409 (63%)

694 (70%)

Phonophobia

3 (75%)

1 (20%)

1 (5%)

216 (69%)

–

–

315 (49%)

536 (54%)

Dizziness

3 (75%)

2 (40%)

–

82 (26%)

1 (25%)

–

248 (38%)

376 (37%)

Motion Sickness

4 (100%)

2 (40%)

1 (5%)

168 (53%)

–

–

87 (13%)

262 (26%)

Nausea

1 (25%)

5 (100%)

–

238 (76%)

–

–

245 (38%)

489 (49%)

Vomiting

–

5 (100%)

–

199 (63%)

–

191 (29%)

394 (39%)

Total cases

4

5

18

315

4

649

998 (100%)

Photophobia

Oral hygiene status was similar in both groups (P >
0.05). Although daily tooth brushing (98% vs. 96%, P >
0.05) and dental flossing (39% vs. 40%, P < 0.05) were
similar, as might be expected, regular dental visits were
slightly increased to 40%, while dentophobia was increased
to 42% in migraine patients, which was significant (P <
0.05). Tooth wear and abrasion seemed more frequent
in patients with migraine (76%, P < 0.05). DMFT scores

(mean 3.79 vs. 2.71, P < 0.05) and gingival plaque index
scores (mean 1.64 vs. 1.23, P < 0.05) showed significant
differences between the groups (Table 3).
The participants’ statements revealed that during acute
migraine attacks dental care was disrupted for at least 24 h
(Table 3). Of the participants, 64% experienced limitations
in oral hygiene habits, whereas 2% of participants stopped
tooth brushing to avoid triggering pain (P < 0.05).
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Table 3. Oral health and care status amongst patients with migraine.
Group 1
Oral health and dental status

Group 2

P-value

Male

Female

Male

Female

Toothbrush use

330

652

366

594

0.791

Dental floss use

134

142

111

195

0.921

Dental visits

201

309

317

334

0.042*

Dental anxiety and phobia

89

171

67

222

0.037*

Bruxism

121

361

143

150

0.006*

TME disorders

152

240

118

232

0.045*

Tooth wear and abrasion

156

367

133

203

0.001*

Erosions

189

218

80

121

0.005*

DMFT index score ᶧ

3.8

3.7

2.8

2.6

0.000*

Gingival plaque index ᶧ

1.7

1.6

1.4

1.1

0.000*

Oral health care

Oral dental status

Oral indexes

ᶧ: Overall mean values for the patients.
*: Significant difference.

4. Discussion
The incidence of migraine has been reported to be
the highest among middle-aged females (1–3,21,24).
Recent studies reported that the prevalence of migraine
without aura is higher than migraine with aura, and the
more frequent subtype of migraine encountered is of
the tension or chronic migraine subtype (25,26). The
findings of the present study corroborated the findings
of the above mentioned recent studies where it was
observed that subtypes of migraine are very rare and do
not affect the data. Previous research has addressed the
possible associations between migraine and hypertension,
hemorrhagic stroke, and CVDs (15,27). For example,
Ylöstalo et al. (28) demonstrated that relatively low oral
hygiene status among migraine patients was a major
underlying factor of infective endocarditis. Our study also
revealed a positive relationship between the existence of
migraine and oral and dental status. To our knowledge,
our study is the first to look at this relationship using
correlation analyses, investigating the possible effects of
comorbid conditions present to oral hygiene. Although
most studies have suggested that migraine patients are
more likely to be susceptible to hypertension and to have
impaired insulin sensitivity, autoimmune diseases, and
several comorbidities related to these diseases, it should
be investigated whether oral symptoms are the cause
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or consequence of migraine (8,18,29,30). None of the
systemic conditions in migraineurs differed from those of
nonmigraineurs in the present study except for GERD. This
difference could be explained by disturbances in migraine
patients of the parasympathetic branch of the autonomic
nervous system, which controls the gastrointestinal reflexes
(31). In migraineurs, nausea and bulimia, in addition to
GERD, are well-known accompanying symptoms that
affect the oral health (7). Volitional vomiting can provide
short-term relief of pain, but consistent vomiting can lead
to serious complications such as tooth erosion (9,32,33).
The abrasion, thus caused, could explain the low caries risk
but high tooth wear and high fracture incidences in dental
restorations (8,34). The results of our study show that the
presence of migraine was associated with an increased
erosion and abrasion intensity, which leads to dental tissue
susceptibility to dental caries.
TMDs have frequently been associated with both
head and jaw pain; therefore, it is easy to confuse TMDs
with acute migraine attacks (18,35). The pain is usually
localized in the temporomandibular region, and the
type, frequency, and predisposing factors of this pain are
referred to TMDs (36). Although not all migraine patients
suffer from TMDs, the relationship between malocclusion
and migraine cannot be overestimated. It is, however,
unclear whether the cause of malocclusion is TMD or
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skeletal problems (37). In addition, it is not known whether
TMD is one of the main causes of migraine or the effect
of neuropathic muscle contraction during acute migraine
attacks (27,38). In contrast, some parafunctional habits
such as bruxism and masseter hypertrophy are secondary
oral consequences of migraine attacks originating from
TMDs, resulting in extensive tooth wear and abfraction,
which affects oral health dramatically (33). According to
our findings, bruxism caused by TMD resulted in tooth
wear on occlusal surfaces and caused malocclusion, which
has been associated with migraine attacks; it initiated
non-TMD-related (masseter muscle-related) bruxism,
initiating a vicious cycle. This deduction is consistent with
the study by Pistoia et al. (39). In addition, correlation
analysis proved that migraineurs who suffered from TMDs
also had tooth wear, but no positive correlation was found
unless accompanied by bruxism. However, an association
between migraine and TMD has been previously observed
(36), and our results may support the notion that DMFT
and periodontal status are most likely to stem from
comorbid factors such as GERD and vomiting, which lead
to extensive dental hard tissue loss.
Pearson’s analysis also showed a strong correlation
between migraine and DMFT and plaque index scores, as
stated in previous studies. This could be the result of either
susceptible tooth surfaces caused by erosion and abrasion
or a significant increase in dental anxiety and phobias,
which can lead to decreased regular dental visits (40,41).
The importance of migraine headaches in the
population lies in its disability potential (23). Intermittent
dental care leads to significant changes in oral hygiene;
hence, dental and periodontal tissues can suffer. In
addition, the medication used for migraine attacks can
exacerbate these conditions (41). Although there have

been many previous studies showing the relationship
between migraine and oral health, few of these studies have
mentioned the possible effects of migraine attacks on daily
oral health care (42). Along with the discomfort caused
by the headache, the results of our study showed major
effects of interruption of daily dental care routines. Our
research could be useful because it offers the opportunity
to evaluate the possible effects of migraine on oral hygiene
and daily oral care.
According to its intensity and dispersion, pain is
referred from the TMJ to the maxillary and mandibular
posterior areas, as well as the teeth in those areas (43).
According to our findings, the evidence corroborated
our hypothesis of a relationship between migraine and
oral health care, particularly the erosions and tooth
abrasions caused by the stress of upcoming migraine
attacks, supporting the results of the study conducted by
Nixdorf et al. (44). Dental plaque can easily accumulate on
eroded and abraded tooth surfaces, which can cause dental
caries and gingivitis. Within the limitations of this crosssectional study, further investigations and evaluations
must be performed to establish causal relationships
between migraine and oral comorbidities.
In conclusion, patients with migraine headaches who
consulted dental professionals were usually misdiagnosed
and received unnecessary treatments. Most dental
clinicians are unfamiliar with this headache disorder and
its associated oral health problems. In addition, most of
the patients are unaware of their oral health condition
because of chronic migraine disease. The cervical erosions
caused by GERD and the occlusal tooth wear caused by
bruxism are the main problems that must be managed
concomitantly to achieve improved treatment outcomes.
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